Aethlon Medical Pursues 1-for-5 Reverse Stock Split to Restore Nasdaq Compliance

summarizeSummary

Aethlon Medical filed a 1-for-5 reverse stock split to boost its share price and maintain Nasdaq listing compliance, reducing outstanding shares to roughly 650,000.

check_boxKey Events · Corporate Governance and Compliance · AEMD

• 1-for-5 Reverse Stock Split

  Effective July 31, 2026, every 5 shares of Aethlon Medical common stock will be consolidated into 1 share, reducing outstanding shares from approximately 3.25 million to about 650,000.

• Nasdaq Compliance Driver

  The reverse split is intended to bring the company into compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share.

• Authorized Share Reduction

  Authorized common shares will decrease from 100 million to 20 million, aligning the capital structure with the reduced share count.

• No Stockholder Approval Required

  Under Nevada law, the board of directors approved the reverse split without a stockholder vote, as it does not adversely affect any other class of stock and no fractional share cash payments are made.

auto_awesomeAnalysis · AEMD · Industrial Applications And Services

To regain compliance with Nasdaq's minimum bid price rule—a critical listing requirement—Aethlon Medical is executing a 1-for-5 reverse stock split effective July 31, 2026. The move will shrink outstanding shares from approximately 3.25 million to about 650,000. Already under a going-concern warning and reliant on highly dilutive financing, the company is using this defensive maneuver to maintain its exchange listing and preserve access to capital markets. Reverse splits, however, often carry negative sentiment because they can signal financial distress and may be followed by further dilution, especially given the recent $3.3 million offering and ongoing cash burn.